More tools:Markets·Screener·Research·Chat

Harmony Biosciences Holdings, Inc. Common Stock (HRMY) Financial Statements

Harmony Biosciences Holdings, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00WBPG548
XNAS · usd
41.47▼ 0.60 (-1.43%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close42.07
Day's Range41.56 – 43.25
52-Week Range25.52 – 43.49
Volume1.8M
Avg Volume762.4K
Share Statistics
Shares Outstanding
Employees293
ExchangeXNAS
Listed2020-08-19
Share count as of July 31, 2026
Loading Income Statement…
Key questions about Harmony Biosciences Holdings, Inc. Common Stock (HRMY)
What is Harmony Biosciences Holdings, Inc. Common Stock's Market Cap?
Harmony Biosciences Holdings, Inc. Common Stock's Market Cap is $2.4B, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's Enterprise Value?
Harmony Biosciences Holdings, Inc. Common Stock's Enterprise Value is $1.9B, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's Trailing P/E?
Harmony Biosciences Holdings, Inc. Common Stock's Trailing P/E is 13.3×, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's Price / Sales?
Harmony Biosciences Holdings, Inc. Common Stock's Price / Sales is 2.5×, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's EV / Revenue?
Harmony Biosciences Holdings, Inc. Common Stock's EV / Revenue is 2.0×, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's EV / EBITDA?
Harmony Biosciences Holdings, Inc. Common Stock's EV / EBITDA is 7.6×, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's Revenue (TTM)?
Harmony Biosciences Holdings, Inc. Common Stock's Revenue (TTM) is $959.9M, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's Net Income (TTM)?
Harmony Biosciences Holdings, Inc. Common Stock's Net Income (TTM) is $181.3M, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's EBITDA?
Harmony Biosciences Holdings, Inc. Common Stock's EBITDA is $254.5M, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's Diluted EPS (TTM)?
Harmony Biosciences Holdings, Inc. Common Stock's Diluted EPS (TTM) is 3.11, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
Net product revenue
YoY growth+30.3%+16.6%+21.1%+28.7%
Cost of product sold
Gross profit
% of revenue75.8%79.3%71.9%75.1%
Operating expenses:
Research and development
Sales and marketing
General and administrative
Total operating expenses
% of revenue41.6%62.0%56.1%47.7%
Operating income
% of revenue34.2%17.3%15.8%27.3%
Other expense, net
Interest expense
Interest income
Income before income taxes
Income tax expense
Net income
% of revenue28.9%15.1%9.2%21.2%
Basic (in dollars per share)
Diluted (in dollars per share)